Dendritic cell therapy with interferon-α synergistically suppresses outgrowth of established tumors in a murine colorectal cancer model.

Autor: Ishii, S.¹, Hiroishi, K.¹ hiroishi@med.showa-u.ac.jp, Eguchi, J.¹, Hiraide, A.¹, Imawari, M.¹

Publikováno v: Gene Therapy. Jan2006, Vol. 13 Issue 1, p78-87. 10p. 4 Charts, 5 Graphs.

Systemic and Local Cytokine Profile in Biliary Atresia

Autor: Saito, T., Sakamoto, A., Hatano, M., Iwai, J., Higashimoto, Y., Yoshida, H., Riepenhoff-Talty, M., Gouvea, V., Evans, M.J., Tyler, K.L., Sokol, R.J., Oberhaus, S.M., Desmet, V.J., Suskind, D.L., Rosenthal, P., Heyman, M.B., Petersen, C., Davenport, M., Shivakumar, P., Campbell, K.M., Sabla, G.E., Mack, C.L., Tucker, R.M., Lu, B.R., Bezerra, J.A., Tiao, G., Ryckman, F.C., Li, J, Bessho, K., Shinkai, M., Shinkai, T., Puri, P., Stringer, M.D., Nobili, V., Marcellini, M., Giovannelli, L., Wu, J.F., Kao, P.C., Chen, H.L., Urushihara, N., Iwagaki, H., Yagi, T., Narayanaswamy, B., Gonde, C., Tredger, J.M., Hussain, M., Vergani, D., Sakaguchi, S., Yamaguchi, T., Nomura, T., Ono, M., Lan, R.Y., Cheng, C., Lian, Z.X., Sakaki, M., Hiroishi, K., Baba, T., Yang, Y, Liu, Y.J., Tang, S.T., Brindley, S.M., Lanham, A.M., Karrer, F.M., Fontenot, A.P., Uchida, K., Inoue, M., Otake, K., Vejchapipat, P., Poomsawat, S., Chongsrisawat, V., Honsawek, S., Poovorawan, Y., Dong, R., Dong, K., Wang, X., Chen, G., Shen, C., Zheng, S., Mourya, R., Mieli-Vergani, G., Minnick, K.E., Kreisberg, R., Dillon, P.W., Ghoneim, E.M., Sira, M.M., Elaziz, A.M. Abd, Khalil, F.O., Sultan, M.M., Mahmoud, A.B., Fenoglio, D., Bernuzzi, F., Battaglia, F., Beriou, G., Costantino, C.M., Ashley, C.W., Koenen, H.J.P.M., Smeets, R.L., Vink, P.M., Rijssen, E. van, Boots, A.M.

Publikováno v: European Journal of Pediatric Surgery, 27, 280-287
European Journal of Pediatric Surgery, 27, pp. 280-287

Purpose Systemic and local immune environments in human biliary atresia (BA) were analyzed. Methods Plasma concentrations of 19 inflammatory components in 16 preoperative BA patients (median age, 51 days), 13 normal controls (NCs) (44 days), and 15 c

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d2246dbc4297d88a3852409ae1610cb4
https://pubmed.ncbi.nlm.nih.gov/27636194

Interferon-alpha gene therapy in combination with CD80 transduction reduces tumorigenicity and growth of established tumor in poorly immunogenic tumor models.

Autor: Hiroishi, K, Tüting, T, Tahara, H, Lotze, M T

Publikováno v: Gene Therapy. Dec99, Vol. 6 Issue 12, p1988. 7p.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.